---
figid: PMC3690116__nihms481550f1
figlink: /pmc/articles/PMC3690116/figure/F1/
number: F1
caption: 'Schematic model of FGF-2 and FGF-18 signaling pathways in articular cartilage
  and IVD. A: FGF-2 binds to both FGFR1 and FGFR3 with high affinity. The phosphorylation
  of FGFR1 triggers Ras and PKCδ activation, which converge on the Raf-MEK1/2–ERK1/2
  axis. Active ERK1/2 utilizes at least two critical transcription factors, Elk-1
  and RUNX2, to upregulate an array of genes including MMP-13, ADAMTS-4, ADAMTS-5,
  COL10A1, and VEGF. In parallel, PKCδ also activates p38 and JNK, which act in concert
  with ERK1/2 to promote ECM degeneration and inhibition of anabolic activities. The
  binding of FGF-2 to FGFR3 may counteract the FGF-2-induced catabolic pathway, similar
  to that utilized by FGF-18. Therefore, the ratio of FGFR3/FGFR1 is a key to the
  biological outcome of FGF-2. B: FGF-18 specifically binds to FGFR3, which in turn
  activates MAPK and Akt pathways. The MAPK pathway differs from those in FGF-2 signaling,
  because neither Elk-1 nor RUNX2 is activated as a result. The Akt pathway may enhance
  PG deposition and account for the anabolic activity of FGF-18.'
pmcid: PMC3690116
papertitle: Fibroblast Growth Factor Control of Cartilage Homeostasis.
reftext: M.B. Ellman, et al. J Cell Biochem. ;114(4):735-742.
pmc_ranked_result_index: '88776'
pathway_score: 0.8355639
filename: nihms481550f1.jpg
figtitle: Schematic model of FGF-2 and FGF-18 signaling pathways in articular cartilage
  and IVD
year: ''
organisms: Homo sapiens
ndex: 8300b661-df24-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3690116__nihms481550f1.html
  '@type': Dataset
  description: 'Schematic model of FGF-2 and FGF-18 signaling pathways in articular
    cartilage and IVD. A: FGF-2 binds to both FGFR1 and FGFR3 with high affinity.
    The phosphorylation of FGFR1 triggers Ras and PKCδ activation, which converge
    on the Raf-MEK1/2–ERK1/2 axis. Active ERK1/2 utilizes at least two critical transcription
    factors, Elk-1 and RUNX2, to upregulate an array of genes including MMP-13, ADAMTS-4,
    ADAMTS-5, COL10A1, and VEGF. In parallel, PKCδ also activates p38 and JNK, which
    act in concert with ERK1/2 to promote ECM degeneration and inhibition of anabolic
    activities. The binding of FGF-2 to FGFR3 may counteract the FGF-2-induced catabolic
    pathway, similar to that utilized by FGF-18. Therefore, the ratio of FGFR3/FGFR1
    is a key to the biological outcome of FGF-2. B: FGF-18 specifically binds to FGFR3,
    which in turn activates MAPK and Akt pathways. The MAPK pathway differs from those
    in FGF-2 signaling, because neither Elk-1 nor RUNX2 is activated as a result.
    The Akt pathway may enhance PG deposition and account for the anabolic activity
    of FGF-18.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MMP13
  - VEGFC
  - RAF1
  - BRAF
  - FGF18
  - ARAF
  - MAP2K2
  - MAPK3
  - PGF
  - MAP2K1
  - FGFR1
  - HRAS
  - FGFR3
  - FGF2
  - MAPK1
  - COL10A1
  - MAPK10
  - VEGFA
  - VEGFB
  - MAPK9
  - AKT1
  - ADAMTS3
  - ELK1
  - MAPK12
  - MAPK11
  - RUNX2
  - KRAS
  - AKT2
  - ADAMTS5
  - MAPK13
  - NRAS
  - MAPK8
  - UNK
  - VEGFD
  - AKT3
  - MAPK14
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: MMP-13
  symbol: MMP13
  source: hgnc_symbol
  hgnc_symbol: MMP13
  entrez: '4322'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: FGF-18
  symbol: FGF-18
  source: hgnc_alias_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: FGFR1
  symbol: FGFR1
  source: hgnc_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: FGFR3
  symbol: FGFR3
  source: hgnc_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: FGF-2
  symbol: FGF2
  source: hgnc_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: COL10A1
  symbol: COL10A1
  source: hgnc_symbol
  hgnc_symbol: COL10A1
  entrez: '1300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ADAMTS-4
  symbol: ADAMTS-4
  source: hgnc_alias_symbol
  hgnc_symbol: ADAMTS3
  entrez: '9508'
- word: Elk-1
  symbol: ELK1
  source: hgnc_symbol
  hgnc_symbol: ELK1
  entrez: '2002'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Runx2
  symbol: RUNX2
  source: hgnc_symbol
  hgnc_symbol: RUNX2
  entrez: '860'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ADAMTS-5
  symbol: ADAMTS5
  source: hgnc_symbol
  hgnc_symbol: ADAMTS5
  entrez: '11096'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: UNK
  symbol: UNK
  source: hgnc_symbol
  hgnc_symbol: UNK
  entrez: '85451'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3690116__F1
redirect_from: /figures/PMC3690116__F1
figtype: Figure
---
